Search clinical trials for: LY2940680

Total 8 results

Eli Lilly and Company

Completed

A Study of LY2940680 in Japanese Participants With Advanced Cancers

Neoplasm Metastasis

Japan
Eli Lilly and Company

Withdrawn

A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma

Medulloblastoma, Childhood | Rhabdomyosarcoma

United States
Eli Lilly and Company

Completed

A Study in Advanced Cancer

Advanced Cancer

United States
Eli Lilly and Company

Completed

A Study of LY2940680 in Healthy Participants

Healthy Volunteers

United States
Eli Lilly and Company

Completed

A Study of LY2940680 in Healthy Participants

Healthy Participants

United States
Eli Lilly and Company

Terminated

A Study of LY2940680 in Small Cell Lung Cancer

Small Cell Lung Carcinoma

United States, United Kingdom
Eli Lilly and Company

Completed

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Soft Tissue Sarcoma | Breast Cancer | Solid Tumor | Cholangiocarcinoma | Colon Cancer

United States, France, Spain, Denmark
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer

Gastroesophageal Junction Adenocarcinoma | Stage IB Esophageal Adenocarcinoma AJCC v7 | Stage II Esophageal Adenocarcinoma AJCC v7 | Stage IIA Esophageal Adenocarcinoma AJCC v7 | Stage IIB Esophageal Adenocarcinoma AJCC v7 | Stage IIIA Esophageal Adenocarcinoma AJCC v7 | Stage IIIB Esophageal...

United States

Search clinical trials for: LY2940680

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations